Equities

Molecular Pharmacology (USA) Ltd

MLPH:PKL

Molecular Pharmacology (USA) Ltd

Actions
  • Price (USD)0.0001
  • Today's Change0.00 / 0.00%
  • Shares traded10.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 17:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2014, cash reserves at Molecular Pharmacology (USA) Ltd fell by 4.67k. Cash Flow from Financing totalled 162.80k or -- of revenues. In addition the company used 105.41k for operations while cash from investing was breakeven.
Cash flow per share-0.0009
Price/Cash flow per share--
Book value per share-0.0188
Tangible book value per share-0.0188
More ▼

Balance sheet in USDView more

Molecular Pharmacology (USA) Ltd uses little or no debt in its capital structure.
Current ratio0.0042
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.